Advertisement

May 21, 2013

Drug and Device Development Outsourcing

As companies outsource drug and device development overseas, reducing development time and research and development costs, additional legal concerns are raised.  Last month a Shanghai court sentenced a researcher, employed by a leading Chinese pharmaceutical research firm, with 18 months’ probation, and ordered the employee to pay restitution for stealing and selling two patented compounds, owned by Merck.

The compounds were developed at the research firm, on behalf of Merck.  Apparently the employee gained access to the compounds and sold them illegally.  This case raises two important issues for manufacturers who outsource.  First, can the outsourcing agreements with research firms adequately protect intellectual property rights and data from this type of misappropriation?  Secondly, do patent portfolio strategies need to take into consideration these types of risks?  To learn more about the case see the article attached….

Read More

©2013 Drinker Biddle & Reath LLP. All Rights Reserved

About the Author

Counsel

Leslie M. Tectoris counsel in the firm's Health Care Practice Group. Her practice focuses on research compliance, regulatory health care and general corporate matters.

Leslie publishes in the Life Sciences Now blog.

414-221-6055

Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. NLR does not accept advertising from attorneys or law firms. The National Law Review is not a law firm nor is www.NatLawReview.com  intended to be an advertisement or a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.